A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.

Clinical trial NCT00601172 · COMPLETED

Trial details

NCT number: NCT00601172
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Nausea and Vomiting, Chemotherapy-Induced

Start date: 2008-03-10
Primary completion: 2009-04-13
Enrollment: 710

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.